Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.
D018528:ATP-Binding Cassette Transporters; D002453:Cell Cycle / Q000502:physiology; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D041321:Chromosomes, Human, X; D024042:Collagen Type I / Q000235:genetics; D000090602:Collagen Type I, alpha 1 Chain; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D005786:Gene Expression Regulation; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D045586:Intranuclear Inclusion Bodies / Q000378:metabolism*; D008297:Male; D005810:Multigene Family; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D000071156:Promyelocytic Leukemia Protein; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D012044:Regression Analysis; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D025521:Tumor Suppressor Proteins
D018528:ATP-Binding Cassette Transporters; D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D015395:Histocompatibility Antigens Class I; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D034741:RNA, Small Interfering; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C477327:transporter associated with antigen processing (TAP); C070576:PML protein, human